CVA Family Office’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Sell |
4,412
-36
| -0.8% | -$6.68K | 0.12% | 113 |
|
|
2025
Q1 | $932K | Buy |
4,448
+383
| +9% | +$80.2K | 0.14% | 103 |
|
|
2024
Q4 | $722K | Buy |
4,065
+220
| +6% | +$39.1K | 0.11% | 119 |
|
|
2024
Q3 | $759K | Buy |
3,845
+152
| +4% | +$30K | 0.12% | 114 |
|
|
2024
Q2 | $633K | Buy |
3,693
+224
| +6% | +$38.4K | 0.11% | 120 |
|
|
2024
Q1 | $632K | Buy |
3,469
+103
| +3% | +$18.8K | 0.11% | 119 |
|
|
2023
Q4 | $522K | Sell |
3,366
-12
| -0.4% | -$1.86K | 0.1% | 127 |
|
|
2023
Q3 | $504K | Buy |
3,378
+465
| +16% | +$69.3K | 0.11% | 124 |
|
|
2023
Q2 | $392K | Sell |
2,913
-178
| -6% | -$24K | 0.08% | 141 |
|
|
2023
Q1 | $493K | Buy |
3,091
+240
| +8% | +$38.2K | 0.11% | 123 |
|
|
2022
Q4 | $461K | Sell |
2,851
-25
| -0.9% | -$4.04K | 0.11% | 121 |
|
|
2022
Q3 | $386K | Sell |
2,876
-60
| -2% | -$8.05K | 0.1% | 122 |
|
|
2022
Q2 | $450K | Buy |
2,936
+150
| +5% | +$23K | 0.12% | 104 |
|
|
2022
Q1 | $452K | Buy |
2,786
+685
| +33% | +$111K | 0.11% | 107 |
|
|
2021
Q4 | $284K | Buy |
2,101
+1,801
| +600% | +$243K | 0.07% | 139 |
|
|
2021
Q3 | $26K | Sell |
300
-1,846
| -86% | -$160K | 0.02% | 240 |
|
|
2021
Q2 | $242K | Buy |
2,146
+526
| +32% | +$59.3K | 0.07% | 142 |
|
|
2021
Q1 | $175K | Buy |
1,620
+1,320
| +440% | +$143K | 0.07% | 129 |
|
|
2020
Q4 | $32K | Hold |
300
| – | – | 0.02% | 232 |
|
|
2020
Q3 | $26K | Buy |
+300
| New | +$26K | 0.02% | 240 |
|